Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06372366

Oral Manifestations in Egyptian Children With Short Stature

Children with short stature have been reported to show a higher prevalence of enamel hypoplasia, delayed tooth eruption, and malocclusion compared to children of normal growth status

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Normal growth is a process in which a single cell develops into a fully grown adult. The growth rate decelerates from the embryonic stage to adulthood, except during puberty. Most adults fall within a narrow range of stature, typically between 1.5 to 2 meters. Variations in height among children are largely determined by a set of genes inherited from their parents. These genes influence stature distribution within the normal range for nearly 95% of the population, with variation generally being benign.

Short stature in children-defined as a height-for-age below -2 standard deviations (SD) from the WHO growth reference-typically corresponding to the 2.3rd percentile, though many texts use the 3rd percentile as the cutoff. Short stature can be assessed using various anthropometric instruments. The condition may be physiological, with no abnormalities other than stature (polygenic short stature), or pathological, resulting from systemic illnesses, nutritional deficiencies, psychosocial factors, hormonal imbalances, genetic disorders, or musculoskeletal pathologies. A subset of infants born small for gestational age (SGA) may be at risk of persistent short stature.

Children with short stature have been reported to show a higher prevalence of enamel hypoplasia, delayed tooth eruption, and malocclusion compared to children of normal growth status . These oral manifestations may result from shared pathogenic mechanisms, such as nutritional deficits, systemic disturbances during enamel formation, or hormonal imbalances affecting growth and development. A clearer understanding of these associations may enhance multidisciplinary screening and care.

This study aims to investigate the prevalence and characteristics of oral manifestations in Egyptian children with short stature, contributing to the limited regional data on this topic.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • - Egyptian children aged 6-12 years.
  • - Diagnosed with short stature (height-for-age < -2 SD based on WHO standards).
  • - Diagnosed and confirmed by a pediatric endocrinologist.

Controls:

  • - Age- and sex-matched children with normal height (height-for-age between -1 and +1 SD).
  • - Recruited from the same geographic and socioeconomic backgrounds.

Exclusion criteria

  • 1- Presence of syndromic conditions (e.g., Turner syndrome, Down syndrome).
  • 2- Chronic diseases (e.g., renal, cardiac, or endocrine conditions other than idiopathic short stature).
  • 3- Long-term medication use known to affect growth or oral development.

Treatment and study plan

Primary outcomes

  1. Dental enamel defects

    Time frame: 3 months

    using Aine's classification

  2. Delayed dental eruption

    Time frame: 3 months

    using Dental eruption table

  3. Malocclusion

    Time frame: 3 months

    using Angle classification

  4. Dental caries experience

    Time frame: 3 months

    using def+DMF

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Oral Manifestations in a Group of Egyptian Children With Short Stature and a Group of Healthy Egyptian Children : A Cross Sectional Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 18, 2024
Registry last updated
Dec 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.